→ Prices of scholarly publications must be reasonable.
→ Information must be openly available.
→ Transition to open access must be possible without any additional costs.
In 2018 more than 1,000 open access articles were published in the journals of various publishers under agreements negotiated by the FinELib consortium.→ Read more
Take advantage of
open access benefits
During negotiations, open access benefits have been agreed upon regarding the journals of the following publishers:
American Chemical Society | Elsevier | Emerald | Royal Society of Chemistry | Sage | Science Advances | Springer Nature | Wolters Kluwer/Lippincott
More information about publisher- and organisation-specific open access benefits is also available from your own library.